Hyperbaric Oxygen Therapy Devices Market Size, Share & Trends Analysis Report By Product (Monoplace, Multiplace, Topical HBOT Devices), By Application (Wound Healing, Infection Treatment, Gas Embolism), By Region,- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2034

Hyperbaric Oxygen Therapy Devices Market Size and Trends

The hyperbaric oxygen therapy devices market size was exhibited at USD 3.25 billion in 2024 and is projected to hit around USD 5.29 billion by 2034, growing at a CAGR of 5.0% during the forecast period 2024 to 2034.

Hyperbaric Oxygen Therapy Devices Market Key Takeaways:

• The Monoplace HBOT devices segment accounted for the largest revenue share in 2024.
• The monoplace HBOT devices segment is anticipated to exhibit the fastest CAGR over the forecast period from 2024 to 2034.
• The others segment is expected to grow at the fastest CAGR of 6.5% during the forecast period.
• North America was the leading segment, accounting for the largest revenue share of 32.0% in 2024.
• The Asia Pacific segment is expected to grow at the fastest CAGR of 5.4% during the forecast period.

U. S. Hyperbaric Oxygen Therapy Devices Market Size and Growth 2024 to 2034

The U.S. hyperbaric oxygen therapy devices market size is evaluated at USD 0.78 billion in 2024 and is projected to be worth around USD 1.28 billion by 2034, growing at a CAGR of 4.6% from 2024 to 2034.

North America was the leading segment, accounting for the largest revenue share of 32.0% in 2024. Emerging economies such as India, China, the Philippines, Vietnam, and Brazil have been experiencing strong economic growth. The increasing population and rising need for wound healing treatment have spurred the demand for HBOT in the region. Growing disposable income has triggered consumers to avail themselves of technologically advanced medical treatments and therapies. In Feb 2023, Maui Memorial Medical Center in the U.S. launched a wound care clinic with hyperbaric oxygen therapy, which offers a comprehensive approach to non-healing wounds. Similarly, in February 2023, HCA Florida Woodmont Hospital introduced the Wound Care and Hyperbaric Center, partnering with specialists in wound care and hyperbaric medicine.

According to the American Venous Forum, advanced venous diseases characterized by skin changes and leg ulceration affect over 2.5 million people annually in the U.S. The increasing prevalence of chronic & acute wounds and simultaneously growing treatment rate due to the presence of developed healthcare technology, growing healthcare expenditure by the government, and huge disposable income are expected to boost the market over the coming years. North Carolina military veterans suffering from traumatic brain injuries and post-traumatic stress disorder receive relief through hyperbaric oxygen therapy (HORT). The therapy, administered at Durham's Extivita clinic, uses 100% oxygen under two hypobaric chambers, funded by the General Assembly.

However, the Asia Pacific segment is expected to grow at the fastest CAGR of 5.4% during the forecast period. This region is anticipated to deliver enormous growth due to increasing per capita income, a growing medical tourism industry, and rising public awareness regarding the benefits of HBOT devices. China is anticipated to witness significant growth in the Asia-Pacific region. In August 2024, HBOT-India launched one of the First Medical Grade Hyperbaric Oxygen Therapies in Gurugram, Delhi NCR, India. In January 2023, Kamalaya Koh Samui in Thailand launched new integrative treatments at its Longevity House. They have introduced a series of new treatments to support integrative healing, including IV vitamin infusions, ozone therapy, hyperbaric oxygen therapy, and high-sensitivity cancer screening.

Report Scope of Hyperbaric Oxygen Therapy Devices Market

Hyperbaric Oxygen Therapy Devices Market By Product Insights

Based on the product, the market is segmented into multiplace HBOT devices, monoplace HBOT devices, and topical HBOT devices. The Monoplace HBOT devices segment accounted for the largest revenue share in 2024. The high adoption rate and commercial availability of monoplace systems, due to their ease of handling and minimum requirement of hospital gas supply, are some of the key factors that can be accounted for its larger revenue share. A few products by major companies such as BARA-MED, BARA-MEDXD, BARA-MED Select by ETC Hyperbaric Chambers; PAH-S1-3800 Hyperbaric Chamber & PAH-S1 Hyperbaric Chamber by Pan-America Hyperbarics, Inc. are widely used. The Hyperbaric Treatment Unit (HTU) at ADK Hospital uses Monoplace HBOT chambers to heal burns and non-healing wounds and treat decompression sickness.

Moreover, the monoplace HBOT devices segment is anticipated to exhibit the fastest CAGR over the forecast period from 2024 to 2034. The growing demand for monoplace systems in hospitals & clinics due to their higher availability and ease of installation is also a pivotal factor expected to drive the market further. The technological advancement related to monoplace systems, such as portability, and some other features, such as user-friendly operability and low maintenance costs, are anticipated to propel the HBOT Equipment market growth over the coming few years.

Some frequently used & commercially available multiplace systems include OxyHeal 5000 rectangular multiplace hyperbaric chamber, OxyHeal 4000 multiplace hyperbaric chamber, and decompression hyperbaric chamber. Multiplace hyperbaric chamber is also expected to grow significantly over the forecast period. Multiplace systems are more expensive and require a larger workforce to maintain & operate. However, the growing requirement to treat more patients in one cycle has increased demand for such systems in large-scale hospitals, which is anticipated to drive the hyperbaric oxygen therapy devices market over the forecast period.

In addition, these devices can accommodate many patients with various conditions and facilitate medical staff monitoring of every patient’s signs and symptoms. Thus, the overall cost of the services for patients is low compared to monoplace devices, raising the adoption rate of such devices. One of the key Unique Selling Propositions (USPs) of multiplace chambers is that they allow extended patient treatment time. The increasing awareness among hospital professionals regarding the benefits of this system is anticipated to boost the HBOT Equipment market.

Hyperbaric Oxygen Therapy Devices Market By Application Insights

According to the estimates reported in the NCBI, about 1 to 2% of the total population of developed nations will experience a chronic wound in their lifetime. In emerging economies, the share is expected to be higher. Moreover, the rising threat of chronic wounds due to the increasing prevalence of diabetes and obesity is also among some contributing factors.

The increasing popularity of adventure activities and leisure sports amongst most of the global population also drives the need for HBOT systems in wound healing applications. In addition, commercially available products such as BARA-MEDXD, BARA-MED, BARA-MED Select, BARA-PRESS Software Control System, and PAH-S1 Hyperbaric Chamber are majorly used for wound healing and decompression sickness. Such a huge product portfolio for treating chronic wounds is also among the few factors that can account for the largest market share.

The others segment is expected to grow at the fastest CAGR of 6.5% during the forecast period. The increasing number of clinical trials with hyperbaric oxygen therapy equipment for conditions such as periodontitis, diabetes mellitus, aging, hypoxic-ischemic encephalopathy, and diabetic foot ulcer outcome is a key determinant indicating the lucrative growth of the other segment. Some of the sponsors of these clinical trials are Loma Linda University and Nanfang Hospital of Southern Medical University. According to the European Society of Cardiology, cardiovascular disease (CVD) each year causes 3.9 million deaths in Europe and over 1.8 million in the European Union. The study by ESC suggests that hyperbaric oxygen therapy (HBOT) promotes recovery of cardiac function in patients with post-COVID syndrome.

Some of the prominent players in the hyperbaric oxygen therapy devices market include:

• Fink Engineering
• ETC Hyperbaric Chambers (Environmental Tectonics Corporation)
• HAUX-LIFE-SUPPORT
• Gulf Coast Hyperbarics, Inc.
• HEARMEC
• IHC Hytech B.V. (Royal IHC)
• Hyperbaric SAC
• Sechrist Industries, Inc.
• OxyHeal International
• SOS Group Global Ltd

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the hyperbaric oxygen therapy devices market

By Product

• Monoplace HBOT devices
• Multiplace HBOT devices
• Topical HBOT devices

By Application

• Wound healing
• Decompression sickness
• Infection treatment
• Gas embolism
• Others

By Regional

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)